Maatje D.A. van Gastel

Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease

Esther Meijer, Folkert W. Visser, R. Aerts et al. · JAMA · 2018 · 102 citations · Full text

Automatic Measurement of Kidney and Liver Volumes from MR Images of Patients Affected by Autosomal Dominant Polycystic Kidney Disease

Maatje D.A. van Gastel, Marie E. Edwards, Vicente E. Torres et al. · Journal of the American Society of Nephrology · 2019 · 89 citations · Full text

Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease

R. Aerts, Wietske Kievit, Hedwig M. A. D‘Agnolo et al. · Gastroenterology · 2019 · 82 citations · Full text

Urology, Hepatology, Medicine +9

Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease

Ron T. Gansevoort, Maatje D.A. van Gastel, Arlene B. Chapman et al. · Kidney International · 2019 · 74 citations · Full text

Inflammation, Plasma Copeptin Levels, Autoimmune Disease +11

Determinants of Urine Volume in ADPKD Patients Using the Vasopressin V2 Receptor Antagonist Tolvaptan

Bart J. Kramers, Maatje D.A. van Gastel, Wendy E. Boertien et al. · American Journal of Kidney Diseases · 2018 · 52 citations · Full text

Adrenal Gland, Adpkd Patients, Voiding Dysfunction +9